For Anduril Industries, the battlefield may be autonomous systems and defense technology. But the more consequential contest for the closely watched private company could be over something less tangible: trust in how government contracts are awarded.

CEO Brian Schimpf says Anduril’s contracts are won “on the merits,” a pointed defense as ethics questions surround co-founder Palmer Luckey’s role within the Pentagon under the Trump administration. That distinction—between the company’s contracting record and the scrutiny around government ties—could become central to how investors assess Anduril’s future.

Schimpf’s comments, reported by CNBC, put the company’s argument in straightforward terms: Anduril believes its performance and capabilities explain its success with the Pentagon. Schimpf also observed that the company has “done incredibly well under Biden as well,” a remark intended to suggest that its progress has not depended solely on one administration’s political alignment.

That is an important point for a defense business. Government procurement is not a single-election story. Contracts can span administrations, while the companies competing for them must persuade officials that their products meet operational needs. By pointing to results under both Biden and Trump, Schimpf is presenting Anduril as a technology provider whose position rests on capability rather than access.

The distinction investors will watch

Yet a defense of the contracting record does not automatically resolve broader questions about government relationships. The ethics scrutiny centers on Luckey’s role within the Pentagon under the Trump administration, while Schimpf’s statement addresses why Anduril says it has won contracts. Those are related subjects, but they are not identical ones.

For investors, that separation matters. A company may argue that its products earned procurement decisions on their merits, while outside observers continue to examine whether government ties could influence perceptions of the process. Even without a finding that a contract was improperly awarded, questions about procurement integrity may affect how private defense-technology companies are viewed.

That reputational layer can be especially significant for a company that is not yet publicly traded. Private-market assessments depend not only on technology and contract momentum, but also on confidence in governance, disclosure and the durability of the business model. Ethics questions involving a prominent co-founder could therefore become part of the conversation surrounding Anduril’s private valuation, even as management emphasizes the company’s record across administrations.

Why a future listing raises the stakes

Anduril could eventually pursue a public listing, although the assignment provides no timetable or valuation. If that happens, the company’s explanation of its government relationships would likely face a wider audience. Public-market investors may examine how Anduril describes its Pentagon contracts, how it separates individual government roles from corporate decisions, and whether scrutiny could affect future procurement perceptions.

That does not mean the current questions determine the outcome of any eventual listing. It does mean they could influence the narrative surrounding one. A public company must explain not only what it sells, but also why customers choose it and whether the relationships supporting its growth are viewed as transparent and appropriate.

For now, Schimpf’s message is both defensive and strategic: Anduril’s contracts, he says, are won “on the merits,” and the company has “done incredibly well under Biden” as well. The investor takeaway is less a verdict than a test. Anduril may be building a case for technological credibility, but government ties can shape the market’s confidence in that case—and confidence can matter greatly when a private defense company eventually steps into public view.